Movicol and Visual acuity reduced - a phase IV clinical study of FDA data

Summary:

Visual acuity reduced is reported as a side effect among people who take Movicol (polyethylene glycol 3350), especially for people who are female, 60+ old, also take Cymbalta, and have Atrial fibrillation/flutter.

The phase IV clinical study analyzes which people have Visual acuity reduced when taking Movicol. It is created by eHealthMe based on reports of 14,199 people who have side effects when taking Movicol from the FDA, and is updated regularly.

What is Movicol?

Movicol has active ingredients of polyethylene glycol 3350. It is often used in constipation. eHealthMe is studying from 14,249 Movicol users. Check the latest studies of Movicol.

What is Visual acuity reduced?

Visual acuity reduced (reduced clearness of vision) is found to be associated with 1,493 drugs and 1,887 conditions by eHealthMe. Check the latest studies of Visual acuity reduced.

On Jul, 12, 2026

14,199 people reported to have side effects when taking Movicol.
Among them, 32 people (0.23%) have Visual acuity reduced.

Could Movicol cause Visual acuity reduced?

Among these 32 people:

What is the gender of people who have Visual acuity reduced when taking Movicol? *

female: 93.1 %
male: 6.9 %

What is the age of people who have Visual acuity reduced when taking Movicol? *

What are other drugs people take besides Movicol? *

What are other side effects people have besides Visual acuity reduced? *

Optic Neuritis (optic nerve inflammation): 21 people, 65.62%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 21 people, 65.62%
Dyspnea (difficult or laboured breathing): 21 people, 65.62%
Depression: 21 people, 65.62%
Hypercapnia (too much smoke): 21 people, 65.62%
Papilloedema (optic disc swelling): 21 people, 65.62%
Pleural Effusion (water on the lungs): 21 people, 65.62%
Cardiac Failure: 21 people, 65.62%
Eye Haemorrhage (bleeding in the eye): 21 people, 65.62%
Tremor (trembling or shaking movements in one or more parts of your body): 21 people, 65.62%

What are the existing conditions these people have? *

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 14 people, 43.75%
Oedema (fluid collection in tissue): 6 people, 18.75%
Cardiac Failure: 5 people, 15.62%
Glaucoma (increased fluid pressure in the eye with vision loss): 3 people, 9.38%
Pain: 3 people, 9.38%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 2 people, 6.25%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 6.25%
Dyspnea (difficult or laboured breathing): 2 people, 6.25%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 6.25%
Feeling Hot: 2 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Movicol and have Visual acuity reduced?

- Check whether Visual acuity reduced is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Movicol:

Movicol (14,249 reports)

Browse all side effects of Movicol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Visual acuity reduced:

Visual acuity reduced (1,493 drugs)

Browse all the conditions that are associated with Visual acuity reduced:

Visual acuity reduced (1,887 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on polyethylene glycol 3350 (the active ingredients of Movicol) and Movicol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.